SBI Securities’s Tenax Therapeutics TENX Stock Holding History

SBI Securities’s Portfolio TENX Stock Details TENX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-2	Closed	-$15	–	4218
2025 Q3	$15	Buy	+2	New	+$12	﹤0.01%	3968
2025 Q1	–	Sell	-5	Closed	-$31	–	4200
2024 Q4	$31	Buy	+5	New	+$24	﹤0.01%	3743

Other funds holding TENX

Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

BFM

Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

SBI Securities's TENX Position: Q4 2025 in Review

SBI Securities sold out of Tenax Therapeutics (TENX) in Q4 2025, closing a stake of 2 shares — an estimated $15 sold.

SBI Securities first reported a position in TENX in Q4 2024 and held it in 2 quarters. The position peaked at $31 in Q4 2024. 48 funds tracked by Wall St. Rank hold TENX as of Q4 2025.

SBI Securities reported no remaining Tenax Therapeutics position as of Q4 2025 after selling out during the quarter.
SBI Securities sold 2 Tenax Therapeutics shares in Q4 2025, an estimated $15.
SBI Securities first reported a position in Tenax Therapeutics in Q4 2024 and held it in 2 quarters.
SBI Securities's Tenax Therapeutics position peaked at $31 in Q4 2024.
48 funds tracked by Wall St. Rank held Tenax Therapeutics as of Q4 2025.

Based on SBI Securities's 13F filing for Q4 2025, filed 3 Feb 2026.